Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced that it has completed the previously announced divestiture of its International Pharmaceuticals business, primarily operated ...

Endo stopped selling Opana ER in 2017, the company noted. While the DOJ touted the federal government's civil and criminal deals, the financial figures from those agreements are not actually relevant.

Before the broad deal, Endo in September 2021 agreed to pay $50 million to settle opioid lawsuits in New York. In late 2021, the company reached a $63 million opioid settlement with Texas. In ...

Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm Endo’s shareholders will receive $80 million in cash and own 49.9% of the combined company for a pro forma enterprise deal ...

Endo International PLC, a pharmaceutical manufacturer facing thousands of lawsuits alleging it fueled the opioid addiction crisis, said Tuesday that it is likely to file for bankruptcy imminently ...

Endo files for bankruptcy as U.S. opioid litigation drags By Reuters August 17, 202210:00 AM PDTUpdated August 17, 2022 ...

Malvern-based Endo has found a merger partner, agreeing to combine with another troubled pharmaceutical firm in a deal valued at $6.7 million.